Argent Biopharma Ltd (MGCLF)

[BostonErin]

TD has a $15 fee. I think end of year this company will be over $1 even with the share count. The deals they already have signed brings their quarterly earnings in 2018 to the amount of Alphria and Aurora, their market caps at about $4billion on $12 million quarterly sales. The Derma division at MGC will prob do that alone (VC deal $40M/year is $10 mil a quarter alone) We are lucky we got in early, once volume takes



MGCLF